TAXOTERE is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Docetaxel.
Product ID | 0075-8003_519e570f-c38f-45eb-bdd4-e373691f3d79 |
NDC | 0075-8003 |
Product Type | Human Prescription Drug |
Proprietary Name | TAXOTERE |
Generic Name | Docetaxel |
Dosage Form | Injection, Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-08-02 |
Marketing End Date | 2020-03-31 |
Marketing Category | NDA / NDA |
Application Number | NDA020449 |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | DOCETAXEL |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 2010-08-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020449 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-08-02 |
Marketing End Date | 2020-03-31 |
Ingredient | Strength |
---|---|
DOCETAXEL | 20 mg/mL |
SPL SET ID: | 45e6dce4-92e2-4ad1-bf11-bbcefb753636 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0075-8003 | TAXOTERE | Docetaxel |
0075-8004 | TAXOTERE | Docetaxel |
0143-9204 | Docetaxel | Docetaxel |
0143-9205 | Docetaxel | Docetaxel |
0409-0365 | Docetaxel | DOCETAXEL |
0409-0366 | Docetaxel | DOCETAXEL |
0409-0367 | Docetaxel | DOCETAXEL |
0409-0368 | Docetaxel | DOCETAXEL |
0409-4235 | Docetaxel | DOCETAXEL |
0409-5068 | Docetaxel | DOCETAXEL |
0955-1020 | Docetaxel | Docetaxel |
0955-1021 | Docetaxel | Docetaxel |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TAXOTERE 74693833 1999459 Live/Registered |
AVENTIS PHARMA S.A. 1995-06-26 |
TAXOTERE 74046910 1661411 Live/Registered |
RHONE-POULENC SANTE 1990-04-09 |